Gufic Biosciences profitability ratios
Per cent unless marked ×
| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY22 and earlierAlpha Plus |
|---|
Returns | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | ||||
|---|---|---|---|---|---|
| 10.1% | 10.1% | 12.3% | 19.6% | ||
| 5.1% | 5.1% | 6.2% | 8.8% | ||
| 15.0% | 15.0% | 15.1% | 19.9% | ||
| 10.0% | 9.0% | 9.4% | 11.3% | ||
Margins | |||||
| 16.8% | 16.0% | 16.4% | 18.1% | ||
| 12.8% | 12.8% | 13.9% | 16.0% | ||
| — | 5.5% | −115.9% | — | ||
| 10.1% | 9.2% | 11.5% | 14.3% | ||
| 7.5% | 6.8% | 8.5% | 10.7% | ||
| — | 6.8% | 8.5% | — | ||
| 1.5% | 1.5% | 5.7% | −14.9% | ||
Additional | |||||
| 26.0% | 25.8% | 26.0% | 25.5% | ||
| — | 1.6% | 1.4% | 1.1% | ||
| 10.1% | 10.0% | 12.1% | 19.3% | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.